Apogee Therapeutics, Inc.APGENASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-172.33M
↓ 96% below average
Average (2y)
$-87.89M
Historical baseline
Range
High:$-16.43M
Low:$-172.33M
CAGR
+223.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-172.33M | -130.0% |
| 2023 | $-74.93M | -356.1% |
| 2022 | $-16.43M | - |